April 17 (Reuters) - NRX Pharmaceuticals Inc NRXP.O:
NRX PHARMACEUTICALS INC - INCREASES MAXIMUM AGGREGATE OFFERING PRICE UNDER AUG 14 2023 ATM AGREEMENT TO $20 MILLION - SEC FILING
Source text: [ID:n0001437749-25-012303]
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.